Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins
Blaeschke, F; Stenger, D; Apfelbeck, A; Cadilha, BL; Benmebarek, MR; Mahdawi, J; Ortner, E; Lepenies, M; Habjan, N; Rataj, F; Willier, S; Kaeuferle, T; Majzner, RG; Busch, DH; Kobold, S; Feuchtinger, T
Feuchtinger, T (corresponding author), Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Dept Pediat Hematol Oncol & Stem Cell Tran, Univ Hosp, Munich, Germany.; Feuchtinger, T (corresponding author), German Canc Consortium DKTK, Partner Site Munich, Munich, Germany.
BLOOD CANCER JOURNAL, 2021; 11 (6):
